EU can lead biotech’s ‘third wave’, but must change how it values innovation

EURACTIV - Bayer's Benelux head, Niels Hessmann, says Europe has the potential to lead the next wave of biotech innovation. The company is pouring billions into a "third wave" of therapies that aim not just to treat symptoms but to stop or even reverse disease. Read more

Niels Hessmann, Managing Director, Bayer BV Benelux [Photo Credit: Bayer BV Benelux]